Zinc finger protein 32 promotes breast cancer stem cell-like properties through directly promoting GPER transcription
暂无分享,去创建一个
Yuquan Wei | Kai Li | Yanyan Li | Di Gong | Jie Zhang | Le Zhang | R. Xiang | P. Lin | Qianwen Zheng | Yafei Guo | Gang Zhao | Yue Zhang | Yue Chen | Hongjiang Li | Shu Zhang
[1] G. Ball,et al. Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients , 2018, Oncotarget.
[2] Jun S. Song,et al. microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway , 2018, Cell Death & Disease.
[3] Wen-Qi Jiang,et al. Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis , 2018, Cell Death & Disease.
[4] Chen Ding,et al. Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7 , 2017, Nature Communications.
[5] Jie Yuan,et al. GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis. , 2017, International journal of oncology.
[6] R. Lv,et al. Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells , 2017, Oncology letters.
[7] C. Simón,et al. Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis , 2017, Stem cells.
[8] C. Gasch,et al. Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention , 2017, Molecular Cancer.
[9] Xin Ma,et al. KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1. , 2017, Cancer research.
[10] M. Al-Alwan,et al. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self‐Renewal Pathway , 2016, Stem cells.
[11] B. Li,et al. Upregulation and activation of δ‑opioid receptors promotes the progression of human breast cancer. , 2016, Oncology reports.
[12] J. Zhang,et al. ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma , 2016, Cell Death and Disease.
[13] Kai Li,et al. Loss of ZNF32 augments the regeneration of nervous lateral line system through negative regulation of SOX2 transcription , 2016, Oncotarget.
[14] H. Mukhtar,et al. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis , 2016, Oncotarget.
[15] S. Lindsey,et al. GPER-novel membrane oestrogen receptor. , 2016, Clinical science.
[16] H. Klocker,et al. GPR30 Promotes Prostate Stromal Cell Activation via Suppression of ERα Expression and Its Downstream Signaling Pathway. , 2016, Endocrinology.
[17] H. Wakimoto,et al. At the Crossroads of Cancer Stem Cells, Radiation Biology, and Radiation Oncology. , 2016, Cancer research.
[18] E. Jang,et al. Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer , 2015, Journal of breast cancer.
[19] V. Rossi,et al. Prostate cancer stem cells: the role of androgen and estrogen receptors , 2015, Oncotarget.
[20] Yuquan Wei,et al. ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription , 2015, Oncotarget.
[21] Lara J. Monteiro,et al. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance , 2015, Oncogene.
[22] Le Zhang,et al. ZNF32 inhibits autophagy through the mTOR pathway and protects MCF-7 cells from stimulus-induced cell death , 2015, Scientific Reports.
[23] C. Walsh,et al. Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt , 2015, Genes & development.
[24] A. Shilatifard,et al. Zic2 is an enhancer-binding factor required for embryonic stem cell specification , 2015, Molecular cell.
[25] Jun Yu,et al. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer , 2015, Oncotarget.
[26] Zhiliang Wang,et al. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[27] E. Prossnitz,et al. G Protein–Coupled Estrogen Receptor Regulates Mammary Tumorigenesis and Metastasis , 2014, Molecular Cancer Research.
[28] Alexander M. Many,et al. Both Canonical and Non-Canonical Wnt Signaling Independently Promote Stem Cell Growth in Mammospheres , 2014, PloS one.
[29] Kai Li,et al. Zinc finger protein 637 protects cells against oxidative stress-induced premature senescence by mTERT-mediated telomerase activity and telomere maintenance , 2014, Cell Death and Disease.
[30] E. Prossnitz,et al. Estrogen biology: New insights into GPER function and clinical opportunities , 2014, Molecular and Cellular Endocrinology.
[31] A. Noske,et al. The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer , 2014, PloS one.
[32] Zhenhua Li,et al. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer , 2013, Breast Cancer Research.
[33] D. Kufe,et al. MUC1-C Oncoprotein Activates ERK→C/EBPβ Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells* , 2013, The Journal of Biological Chemistry.
[34] G. Landberg,et al. Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms , 2012, Clinical Cancer Research.
[35] R. Clarke,et al. A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity , 2012, Journal of Mammary Gland Biology and Neoplasia.
[36] A. Vivacqua,et al. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells , 2012, Breast Cancer Research and Treatment.
[37] Yuquan Wei,et al. Establishment of a monoclonal antibody against a peptide of the novel zinc finger protein ZNF32 proved to be specific and sensitive for immunological measurements , 2012, Medical science monitor : international medical journal of experimental and clinical research.
[38] P. Thomas,et al. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. , 2012, Endocrinology.
[39] C. Rosano,et al. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells , 2012, Breast Cancer Research.
[40] E. Prossnitz,et al. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. , 2011, Endocrinology.
[41] A. Roessner,et al. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer , 2011, Breast Cancer Research and Treatment.
[42] Fang Yu,et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion , 2010, Oncogene.
[43] N. Joste,et al. GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer , 2010, Breast Cancer Research and Treatment.
[44] M. Maggiolini,et al. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. , 2010, Cancer research.
[45] F. Bertucci,et al. Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer , 2009, Clinical Cancer Research.
[46] G. Smyth,et al. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.
[47] Jiang Shou,et al. Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts. , 2008, Cancer research.
[48] M. Mimeault,et al. Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies , 2008, Clinical pharmacology and therapeutics.
[49] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[50] D. Giri,et al. Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression , 2006, Clinical Cancer Research.
[51] Danila Coradini,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.
[52] J. Chen,et al. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer. , 2015, Cancer research.